The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Tibalosin     1-(2,3-dihydrobenzothiophen- 5-yl)-2-(4...

Synonyms: SureCN1254588, AC1L4SDC, AR-1I2736, KB-212541, AC1Q3F37, ...
This record was replaced with 163028.
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of 1-(2,3-dihydrobenzothiophen-5-yl)-2-(4-phenylbutylamino)propan-1-ol


High impact information on 1-(2,3-dihydrobenzothiophen-5-yl)-2-(4-phenylbutylamino)propan-1-ol


Associations of 1-(2,3-dihydrobenzothiophen-5-yl)-2-(4-phenylbutylamino)propan-1-ol with other chemical compounds


Analytical, diagnostic and therapeutic context of 1-(2,3-dihydrobenzothiophen-5-yl)-2-(4-phenylbutylamino)propan-1-ol


  1. Effects of tibalosine, a new alpha-adrenoceptor antagonist, in essential hypertension. Staessen, J., Fagard, R., Grauwels, R., Lijnen, P., Verschueren, L.J., Amery, A. Clin. Pharmacol. Ther. (1983) [Pubmed]
  2. Alpha-adrenoceptor blockade by tibalosine: hemodynamic and humoral effects at rest and during exercise, and effect of opioid receptor antagonism. Staessen, J., Fiocchi, R., Fagard, R., Lijnen, P., Amery, A. J. Cardiovasc. Pharmacol. (1986) [Pubmed]
  3. Chronic treatment with tibalosine in essential hypertension. Staessen, J., Fagard, R., Fiocchi, R., Lijnen, P., M'Buyamba-Kabangu, J.R., Amery, A. Archives internationales de pharmacodynamie et de thérapie. (1986) [Pubmed]
  4. Receptor binding profile of tibalosine, a new antihypertensive. Chatelain, P., Friedhoff, A.J., Meller, E., Mennini, T., Gorissen, H., Roba, J. Arzneimittel-Forschung. (1984) [Pubmed]
  5. Antihypertensive activity and interaction with alpha-adrenoceptors of tibalosine ([1-(2, 3-dihydro-5-benzo-(b)-thienyl)-2-(4-phenyl-butylamino)-1-propanol], CP 804 S) in rat and cat preparations. Qian, J.Q., Mathy, M.J., Thoolen, M.J., Timmermans, P.B., van Zwieten, P.A. Archives internationales de pharmacodynamie et de thérapie. (1983) [Pubmed]
  6. Influence of central alpha 1 inhibition in patients with essential hypertension. Lijnen, P., Staessen, J., Fagard, R., Amery, A. Chest (1983) [Pubmed]
WikiGenes - Universities